Shilpa Medicare (SHILPAMED): Press Release

Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par

1 min read Shilpa Medicare

Press Release

Press Release

Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy".

Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy".

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#SHILPA MEDICARE LTD #SHILPAMED #Corporate announcement

Track Indian stocks with ZTOX AI

Get started free

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Insider Deals Alert
Volume Breakouts
Block Deal Notifications
Preferential Issue Alerts
Free ₹0
Basic ₹89/mo
Advanced ₹119/mo
No credit card required to start on the free plan.
Start Free Now